Robert E. Hoffman

Insider Reports History

Entity: Individual
Location: Arena Pharmaceuticals Inc, 6166 Nancy Rider Drive, San Diego, CA
Signature: /s/ Sheldon L. Koenig, by power of attorney
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Esperion Therapeutics, Inc.	Director	Stock Option (right to buy)	40K	$64.8K	$1.62	Apr 1, 2025	Direct
FibroBiologics Inc.	Director	Common Stock	7.5K	$14.4K	$1.91	Jan 24, 2024	Direct
TuHURA Biosciences, Inc./NV	Director	Options (Right to Buy)	51.3K			Jan 2, 2025	Direct
Kura Oncology, Inc.	Director	Option to purchase common stock	23K			Jun 22, 2021	Direct
FibroBiologics, Inc.	Director	Stock Option (Right to Buy)	5K			Aug 27, 2024	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ESPR	Esperion Therapeutics, Inc.	Apr 1, 2025	1	$0	4	Apr 2, 2025	Director
ESPR	Esperion Therapeutics, Inc.	Apr 1, 2025	0	$0	3	Apr 2, 2025	Director
HURA	TuHURA Biosciences, Inc./NV	Jan 2, 2025	1	$0	4	Jan 6, 2025	Director
FBLG	FibroBiologics, Inc.	Aug 27, 2024	1	$0	4	Aug 27, 2024	Director
FBLG	FibroBiologics, Inc.	Jan 24, 2024	0	$0	3/A	Aug 13, 2024	Director
FBLG	FibroBiologics Inc.	Jan 24, 2024	0	$0	3	Feb 7, 2024	Director
KTRA	Kintara Therapeutics, Inc.	Aug 30, 2023	1	$0	4	Sep 1, 2023	President, CEO and Interim CFO, Director
KTRA	Kintara Therapeutics, Inc.	Jun 1, 2023	1	$0	4	Jun 2, 2023	President, CEO, and CFO, Director
KTRA	Kintara Therapeutics, Inc.	Aug 1, 2022	2	$0	4	Aug 3, 2022	President and CEO, Director
KTRA	Kintara Therapeutics, Inc.	Feb 15, 2022	1	$25.8K	4	Feb 17, 2022	President and CEO, Director
KTRA	Kintara Therapeutics, Inc.	Nov 8, 2021	1	$0	4	Nov 10, 2021	President and CEO, Director
KTRA	Kintara Therapeutics, Inc.	Sep 22, 2021	1	$0	4	Sep 22, 2021	Director
KURA	Kura Oncology, Inc.	Jun 22, 2021	1	$0	4	Jun 23, 2021	Director